Search Results - "Clark, Stephen Michael"

Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia by Benitez, Lydia L., Perissinotti, Anthony J., Rausch, Caitlin R., Klaus, Jeff, Clark, Stephen Michael, Filtz, Michael, Ratermann, Kelley, Treptow, Carissa, Griffin, Shawn, Olson, Marissa, Crain, Mallory, Kadia, Tapan, Pettit, Kristen, Burke, Patrick W., Bixby, Dale L., Marini, Bernard L.

“…Liposomal daunorubicin/cytarabine (CPX-351) gained FDA approval for secondary AML after demonstrating improved outcomes over daunorubicin and cytarabine (7 +…”
Get full text

Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML by Benitez, Lydia, Perissinotti, Anthony J., Rausch, Caitlin R., Klaus, Jeff, Clark, Stephen Michael, Filtz, Michael, Ratermann, Kelley L, Treptow, Carissa F., Griffin, Shawn, Olson, Marissa, Crain, Mallory, Pettit, Kristen, Burke, Patrick W., Bixby, Dale L., Marini, Bernard Lawrence

“…BACKGROUND Secondary AML (sAML) that develops after an antecedent hematologic disorder or exposure to genotoxic therapy is associated with a poor prognosis and…”
Get full text

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting by DeRemer, David L., Clemmons, Amber B., Orr, Julianne, Clark, Stephen Michael, Gandhi, Arpita Shah

“…The prevention and treatment of chemotherapy‐induced nausea and vomiting (CINV) continues to pose a challenge for clinicians. The development of…”
Get full text

Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center by McCaleb, Rachael V., Gandhi, Arpita S., Clark, Stephen Michael, Clemmons, Amber B.

“…Background: Acid suppressive therapy (AST)—namely, proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs)—is routinely prescribed to…”
Get full text

Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation by Bates, Jill S, Auten, Jessica, Sketch, Margaret R, Patel, Tejendra, Clark, Stephen Michael, Morgan, Katherine P, Muluneh, Benyam, McLaughlin, Jacqueline E, Pinelli, Nicole R, Foster, Matthew C, Amerine, Lindsey

“…Background Healthcare systems and policy makers worldwide are demonstrating interest in shared decision making, which requires patient activation. Patient…”
Get full text

Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant by Clark, Stephen Michael, Clemmons, Amber B, Schaack, Lindsay, Garren, Jeonifer, DeRemer, David L, Kota, Vamsi K

“…Purpose To assess the impact of single-dose fosaprepitant on nausea and emesis after BEAM and high-dose melphalan conditioning regimens for autologous…”
Get full text

Markets remain calm in wake of Tokyo fall by Leather Clark Joseph, Stephen Michael Joe

Get full text

Wall Street drops 71 points by Clark Leather Bone, Michael Stephen James

Get full text